Abstract

Cyclic AMP is a ubiquitous intracellular second messenger involved in the regulation of a wide variety of cellular processes, a majority of which act through the cAMP – protein kinase A (PKA) signaling pathway and involve PKA phosphorylation of specific substrates. PKA phosphorylation events are typically spatially restricted and temporally well controlled. A-kinase anchoring proteins (AKAPs) directly bind PKA and recruit it to specific subcellular loci targeting the kinase activity toward particular substrates, and thereby provide discrete spatiotemporal control of downstream phosphorylation events. AKAPs also scaffold other signaling molecules into multi-protein complexes that function as crossroads between different signaling pathways. Targeting AKAP coordinated protein complexes with high-affinity peptidomimetics or small molecules to tease apart distinct protein–protein interactions (PPIs) therefore offers important means to disrupt binding of specific components of the complex to better understand the molecular mechanisms involved in the function of individual signalosomes and their pathophysiological role. Furthermore, development of novel classes of small molecules involved in displacement of AKAP-bound signal molecules is now emerging. Here, we will focus on mechanisms for targeting PPI, disruptors that modulate downstream cAMP signaling and their role, especially in the heart.

Highlights

  • Intracellular 3 -5 -cyclic adenosine monophosphate is an important second messenger that regulates a number of biological processes

  • Signal transduction through the cyclic adenosine monophosphate (cAMP) pathway starts by stimulation of G-protein-coupledreceptors (GPCRs), via specific extracellular ligands leading to activation of adenylyl cyclase (AC), which converts ATP into cAMP

  • The rise in intracellular cAMP levels leads to a set of events mediated by specific effector molecules, hereunder protein kinase A (PKA; Walsh et al, 1968), cyclic nucleotide gated ion channels (Brown et al, 1979) and exchange protein directly activated by cAMP (Epac; de Rooij et al, 1998; Kawasaki et al, 1998)

Read more

Summary

Introduction

Intracellular 3 -5 -cyclic adenosine monophosphate (cAMP) is an important second messenger that regulates a number of biological processes. In this review we will mainly focus on another approach, targeting AKAPs by disrupting the binding between two proteins, i.e., interfering with PPIs. Hundreds of thousands of PPIs probably occur in human cells and are involved in assembly of supramolecular signaling complexes and signalosomes as well as in target-depend signaling by docking and adaptors.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.